期刊
CANCER
卷 126, 期 14, 页码 3176-3180出版社
WILEY
DOI: 10.1002/cncr.32875
关键词
liquid biopsy; lung cancer; molecular testing; NGS; plasma cfDNA
类别
资金
- Princess Margaret Cancer Foundation (OSI Pharmaceuticals Foundation Chair)
There is growing evidence that plasma cell-free DNA testing can aid in the diagnosis of targetable alterations at diagnosis in patients with advanced nonsquamous lung carcinoma. A plasma-first approach will facilitate access to precision medicine, with studies suggesting that nearly 60% of patients could benefit compared with the current approach of tissue profiling alone.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据